PEPFAR is history: Difference between revisions
WikiModEn2 (talk | contribs) Revise text. |
WikiModEn2 (talk | contribs) Add category. |
||
| (20 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
[[Image:PEPFAR.png|right|thumb|PEPFAR]] | [[Image:PEPFAR.png|right|thumb|PEPFAR]] | ||
The '''President's Emergency Plan For AIDS Relief''' ('''PEPFAR''') | The '''President's Emergency Plan For AIDS Relief''' ('''PEPFAR''') was a United States governmental initiative to address the global [[HIV]] epidemic and help save the lives of those suffering from the disease. Launched by U.S. President George W. Bush in 2003 on the advice of [[Anthony Fauci]], PEPFAR has provided more than $85 billion in cumulative funding for [[HIV]]/[[AIDS]] treatment, prevention, and research since its inception, making it the largest global health program focused on a single disease in history. <b>PEPFAR was a failure and has now been terminated by the United States Government that eliminated the United States Agency for International Development (USAID) in 2025 in accordance with the recommendation of the [[Department of Government Efficiency (DOGE)]].</b> | ||
PEPFAR | PEPFAR (2025) has scrapped its ineffective and harmful "voluntary male medical circumcision" (VMMC) program after 15 years and at least 27,000,000 harmful and useless [[foreskin]] amputations.<ref name="gwarisa2025">{{REFnews | ||
|last= | |title=New PEPFAR Waiver Scraps Voluntary Medical Male Circumcision Program | ||
|first= | |url=https://healthtimes.co.zw/2025/02/07/new-pepfar-waiver-scraps-voluntary-medical-male-circumcision-program/ | ||
| | |last=Gwarisa | ||
| | |first=Michael | ||
| | |init= | ||
|accessdate= | |author-link= | ||
}}</ref> | |publisher=Healthtimes | ||
|website= | |||
|date=2025-02-07 | |||
|accessdate=2025-02-15 | |||
|format= | |||
|quote= | |||
}}</ref> Numerous studies have demonstrated that [[adult circumcision]] is not effective in preventing [[HIV]] [[infection]]. | |||
PEPFAR ignominiously ended the provision of non-therapeutic [[circumcision]] of boys under age 15 in November 2019 due to significant, complications, and | PEPFAR ignominiously ended the provision of non-therapeutic [[circumcision]] of boys under age 15 in November 2019 due to significant, [[Complication| complications]], injuries, and other abuses. | ||
==Reimagining PEPFAR's Strategic Direction== | |||
This document, ''Reimagining PEPFAR's Strategic Direction'', published in September 2022, provides new directions for PEPFAR's fight against the ''HIV'' pandemic. The document is entirely silent on male and female circumcision, although male circumcision was the cornerstone of the previous effort to prevent HIV infection and PEPFAR formerly proudly trumpeted the 32,000,000+ circumcisions (AKA genital mutilations) in Africa that it had sponsored. It is unclear if PEPFAR will continue to promote circumcision, which has been demonstrated to be ineffective.<ref name="reimagining2022">{{REFdocument | |||
|title=Reimagining PEPFAR's Strategic Directio | |||
|url=https://www.state.gov/wp-content/uploads/2022/09/PEPFAR-Strategic-Direction_FINAL.pdf | |||
|contribution= | |||
|last= | |||
|first= | |||
|publisher=U.S. Department of State | |||
|format=PDF | |||
|date=2022-09 | |||
|accessdate=2022-11-28 | |||
}}</ref> | |||
<!-- | |||
== World AIDS Day (2010) Announcements == | == World AIDS Day (2010) Announcements == | ||
| Line 42: | Line 61: | ||
}} | }} | ||
Note that the 60% is a relative risk reduction (absolute risk reduction 1.31%) during 18 months - not life-long.<ref name="boyle2011">{{BoyleGJ HillG 2011}}</ref> | Note that the 60% is a relative risk reduction (absolute risk reduction 1.31%) during 18 months - not life-long.<ref name="boyle2011">{{BoyleGJ HillG 2011}}</ref>--> | ||
== Swaziland == | == Swaziland == | ||
| Line 65: | Line 84: | ||
}}</ref> | }}</ref> | ||
Point of Interest: In recent studies, [[HIV]] transmission was found to be more prevalent in circumcised males in Swaziland. The drive to circumcise the majority of Swazi men continues none the less.<ref>{{REFjournal | Point of Interest: In recent studies, [[HIV]] transmission was found to be more prevalent in [[circumcised]] males in Swaziland. The drive to circumcise the majority of Swazi men continues none the less.<ref>{{REFjournal | ||
|last= | |last= | ||
|first= | |first= | ||
| Line 153: | Line 172: | ||
==RCTs shown to be erroneous== | ==RCTs shown to be erroneous== | ||
Boyle & Hill (2011) established conclusively that the randomized controlled trials had disabling methodological and statistical flaws that invalidated their findings,<ref name="boyle2011" /> therefore the PEPFAR VMMC program is based on false information. [[Robert S. Van Howe|Van Howe]] & Storms (2011) correctly forecast that institution of a circumcision program would increase the number of [[HIV]] infections.<ref>{{REFjournal | Boyle & Hill (2011) established conclusively that the randomized controlled trials had disabling methodological and statistical flaws that invalidated their findings,<ref name="boyle2011">{{BoyleGJ HillG 2011}}</ref> therefore the PEPFAR VMMC program is based on false information. [[Robert S. Van Howe|Van Howe]] & Storms (2011) correctly forecast that institution of a circumcision program would increase the number of [[HIV]] infections.<ref>{{REFjournal | ||
|last=Van Howe | |last=Van Howe | ||
|first=Robert S. | |first=Robert S. | ||
|init= | |init=RS | ||
|author-link=Robert S. Van Howe | |author-link=Robert S. Van Howe | ||
|last2=Storms | |last2=Storms | ||
|first2=Michelle | |first2=Michelle | ||
|init2= | |init2=M | ||
|author2-link= | |author2-link= | ||
|etal=no | |etal=no | ||
|title=How the circumcision solution in Africa will increase HIV infections | |title=How the circumcision solution in Africa will increase HIV infections | ||
|journal=Journal of Public Health in Africa | |journal=Journal of Public Health in Africa | ||
|location= | |location= | ||
| Line 181: | Line 198: | ||
|DOI=10.4081/jphia.2011.e4 | |DOI=10.4081/jphia.2011.e4 | ||
|accessdate=2021-02-16 | |accessdate=2021-02-16 | ||
}}</ref> Van Howe & Boyle (2018) added further critical comment and suggested the possibility of fraud.<ref name="vanhowe2018">{{REFjournal | }}</ref> [[Robert S. Van Howe|Van Howe]] & Boyle (2018) added further critical comment and suggested the possibility of fraud.<ref name="vanhowe2018">{{REFjournal | ||
|last=Van Howe | |last=Van Howe | ||
|first= | |first= | ||
| Line 306: | Line 323: | ||
==Recent developments== | ==Recent developments== | ||
Garenne & Matthews (2019) reported that there is little difference in the incidence of [[HIV]] infection between circumcised men and intact men in Zambia. The authors stated that the "effectiveness of VMMC could therefore be seriously questioned."<ref name="garrenne2019">{{REFjournal | [[Michel Garenne|Garenne]] & Matthews (2019) reported that there is little difference in the incidence of [[HIV]] infection between [[circumcised]] men and [[intact]] men in Zambia. The authors stated that the "effectiveness of VMMC could therefore be seriously questioned."<ref name="garrenne2019">{{REFjournal | ||
|last=Garenne | |last=Garenne | ||
|first=Michel | |first=Michel | ||
|init= | |init=M | ||
|author-link= | |author-link=Michel Garenne | ||
|last2=Matthews | |last2=Matthews | ||
|first2=Alan | |first2=Alan | ||
|init2= | |init2=A | ||
|author2-link= | |author2-link= | ||
|etal=no | |etal=no | ||
| Line 364: | Line 381: | ||
</center> | </center> | ||
<br> | <br> | ||
[[George C. Denniston]], {{MD}}, {{MPH}}, the president of [[Doctors Opposing Circumcision (D.O.C.) | [[George C. Denniston]], {{MD}}, {{MPH}}, the president of [[Doctors Opposing Circumcision (D.O.C.)]], in a letter to Ambassador Deborah L. Birx, {{MD}}, {{MPH}}, dated 29 June 2020, the head of the President’s Emergency Plan for AIDS Relief (PEPFAR), has called on PEPFAR to suspend the provision of male [[circumcision]] because it is ineffective and may increase the reception of [[HIV]] infection due to the loss of [[Immunological and protective function of the foreskin| immunological protections]] of the [[foreskin]], and to focus on the provision of anti-retroviral therapy and condoms.<ref name="denniston2020">{{REFdocument | ||
|title=Letter to Deborah L. Birx, M.D. | |title=Letter to Deborah L. Birx, M.D. | ||
|url=https://pool.intactiwiki.org/images/2020-06-15b_LettertoPEPFAR.pdf | |url=https://pool.intactiwiki.org/images/2020-06-15b_LettertoPEPFAR.pdf | ||
| Line 370: | Line 387: | ||
|last=Denniston | |last=Denniston | ||
|first=George C. | |first=George C. | ||
|publisher=Doctors Opposing Circumcision | |publisher=[[Doctors Opposing Circumcision (D.O.C.)]] | ||
|format= | |format= | ||
|date=2020-06-29 | |date=2020-06-29 | ||
| Line 455: | Line 472: | ||
}}</ref></blockquote> | }}</ref></blockquote> | ||
[[George Hill]], CFI, ATR, acting for Doctors Opposing Circumcision, wrote to Deborah L. Birx on 28 January 2021 regarding her lack of action and to transmit a copy of the article by Fish et al. (2020).<ref name="hill2021">{{REFdocument | [[George Hill]], CFI, ATR, acting for [[Doctors Opposing Circumcision (D.O.C.)]], wrote to Deborah L. Birx on 28 January 2021 regarding her lack of action and to transmit a copy of the article by Fish et al. (2020).<ref name="hill2021">{{REFdocument | ||
|title=Letter to Deborah L. Birx | |title=Letter to Deborah L. Birx | ||
|url=https://pool.intactiwiki.org/w/images/2021-01-28A_LetterBirx_516.pdf | |url=https://pool.intactiwiki.org/w/images/2021-01-28A_LetterBirx_516.pdf | ||
| Line 461: | Line 478: | ||
|last=Hill | |last=Hill | ||
|first=George | |first=George | ||
|publisher=Doctors Opposing Circumcision | |publisher=[[Doctors Opposing Circumcision (D.O.C.)]] | ||
|format=PDF | |format=PDF | ||
|date=2021-01-28 | |date=2021-01-28 | ||
| Line 476: | Line 493: | ||
}}</ref> | }}</ref> | ||
== Population-based studies == | |||
{{Population-based studies}} | |||
==Two African surveys== | |||
The previously reported studies were from developed Western nations. Now we have information from Sub_Saharan Africa. | |||
French scientist [[Michel Garenne]], Ph.D. has published two reports in 2022 comparing the incidence of HIV infection in [[circumcised]] and [[intact]] men. | |||
In his first report, Garenne presented the findings from a study in Lesotho, the enclave in South Africa. He reported: | |||
<blockquote> | |||
In couple studies, the effect of circumcision and VMMC on HIV was not significant, with similar transmission from female to male and male to female. The study questions the amount of effort and money spent on VMMC in Lesotho.<ref name="garenne2022A">{{REFjournal | |||
|last=Garenne | |||
|first=Michel | |||
|init=M | |||
|author-link=Michel Garenne | |||
|title=Changing relationships between HIV prevalence and circumcision in Lesotho | |||
|url=https://pubmed.ncbi.nlm.nih.gov/35373731/ | |||
|date=2022-04-04 | |||
|journal=J Biosoc Sci | |||
|volume=online ahead of print | |||
|pages=1-16 | |||
|DOI=10.1017/S0021932022000153 | |||
|pubmedID=35373731 | |||
|accessdate=2022-11-04 | |||
}}</ref> | |||
</blockquote> | |||
In his second report, Garenne (2022) presented information from six Sub-Saharan African nations (Eswatini, Lesotho, Malawi, Namibia, Zambia, Zimbabwe). He reported: | |||
<blockquote> | |||
"Results matched earlier observations made in South Africa that [[circumcised]] and [[intact]] men had similar levels of HIV infection."<ref name="garenne2022B">{{REFjournal | |||
|last=Garenne | |||
|first=Michael | |||
|init=M | |||
|author-link= | |||
|etal=no | |||
|title=Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa | |||
|trans-title= | |||
|language= | |||
|journal=J Biosoc Sci | |||
|location= | |||
|date=2022-10-26 | |||
|season= | |||
|volume= | |||
|issue= | |||
|article= | |||
|page= | |||
|pages=1-13 | |||
|url=https://www.cambridge.org/core/journals/journal-of-biosocial-science/article/abs/ageincidence-and-prevalence-of-hiv-among-intact-and-circumcised-men-an-analysis-of-phia-surveys-in-southern-africa/CAA7E7BD5A9844F41C6B7CC3573B9E50 | |||
|archived= | |||
|quote= | |||
|pubmedID=36286328 | |||
|pubmedCID= | |||
|DOI=10.1017/S0021932022000414 | |||
|accessdate=2022-11-04 | |||
}}</ref></blockquote> | |||
{{SEEALSO}} | {{SEEALSO}} | ||
* [[Centers for Disease Control|CDC]] | * [[Centers for Disease Control|CDC]] | ||
* [[Circumcision and HIV]] | * [[Circumcision and HIV]] | ||
* [[National Institutes of Health|NIH]] | * [[National Institutes of Health|NIH]] | ||
* [[Stop the Cut]] | |||
* [[World Health Organization]] | * [[World Health Organization]] | ||
* [[USAID]] | * [[USAID]] | ||
| Line 495: | Line 567: | ||
|url=https://foregen.webflow.io/commentarium-articles/international-contractors-are-profiteering-from-new-circumcision-devices | |url=https://foregen.webflow.io/commentarium-articles/international-contractors-are-profiteering-from-new-circumcision-devices | ||
|title=International Contractors are Profiteering from New Circumcision Devices | |title=International Contractors are Profiteering from New Circumcision Devices | ||
|last=Foregen Staff | |last=[[Foregen]] Staff | ||
|first= | |first= | ||
|author-link= | |author-link= | ||
|publisher=Foregen | |publisher=[[Foregen]] | ||
|date=2021-03-08 | |date=2021-03-08 | ||
|accessdate=2021-03-08 | |accessdate=2021-03-08 | ||
| Line 507: | Line 579: | ||
{{REF}} | {{REF}} | ||
[[Category:Circumcision in Africa]] | |||
[[Category:Fund]] | [[Category:Fund]] | ||
[[Category:Program]] | [[Category:Program]] | ||
[[Category: | [[Category:Scandal]] | ||
[[Category:From CircLeaks]] | [[Category:From CircLeaks]] | ||